Erlotinib vs Moxifloxacin
Erlotinib vs Moxifloxacin: Overview
This comparison examines the pharmacological differences between Erlotinib and Moxifloxacin.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Moxifloxacin β 12 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Moxifloxacin β C21H24FN3O4.
Molecular Weight: Erlotinib β 393.4380 g/mol; Moxifloxacin β 401.4350 g/mol.
Type: Erlotinib β Small molecule; Moxifloxacin β Small molecule.